Petr Chytil

3.4k total citations
78 papers, 2.9k citations indexed

About

Petr Chytil is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Petr Chytil has authored 78 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Biomaterials, 31 papers in Molecular Biology and 31 papers in Biomedical Engineering. Recurrent topics in Petr Chytil's work include Nanoparticle-Based Drug Delivery (60 papers), Nanoplatforms for cancer theranostics (26 papers) and RNA Interference and Gene Delivery (16 papers). Petr Chytil is often cited by papers focused on Nanoparticle-Based Drug Delivery (60 papers), Nanoplatforms for cancer theranostics (26 papers) and RNA Interference and Gene Delivery (16 papers). Petr Chytil collaborates with scholars based in Czechia, Germany and Japan. Petr Chytil's co-authors include Tomáš Etrych, Karel Ulbrich, Blanka Řı́hová, M. Jelı́nková, Tomáš Mrkvan, Milada Šírová, J. Strohalm, Olga Janoušková, Eva Randárová and Čestmı́r Koňák and has published in prestigious journals such as Langmuir, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Petr Chytil

76 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petr Chytil Czechia	32	1.9k	1.2k	1.1k	728	593	78	2.9k
Cristianne J.F. Rijcken Netherlands	28	2.2k 1.1×	1.2k 1.0×	1.1k 1.0×	1.1k 1.5×	429 0.7×	59	3.6k
Jayant Khandare India	32	1.4k 0.7×	1.1k 1.0×	1.8k 1.7×	600 0.8×	1.1k 1.8×	100	3.8k
Huanli Sun China	32	2.1k 1.1×	1.4k 1.2×	1.1k 1.0×	751 1.0×	530 0.9×	68	3.3k
Takahiro Nomoto Japan	33	1.6k 0.8×	1.5k 1.3×	1.7k 1.6×	419 0.6×	244 0.4×	68	3.5k
Jianbin Tang China	24	1.9k 1.0×	1.9k 1.6×	1.4k 1.3×	583 0.8×	619 1.0×	52	3.8k
Anatoly N. Lukyanov United States	22	1.8k 0.9×	969 0.8×	1.4k 1.3×	440 0.6×	224 0.4×	26	3.2k
Vimalkumar Balasubramanian Finland	25	1.6k 0.8×	1.4k 1.2×	1.2k 1.1×	525 0.7×	231 0.4×	48	3.2k
Hao Su China	32	1.6k 0.8×	743 0.6×	1.1k 1.0×	912 1.3×	259 0.4×	75	2.9k
Michal Pechar Czechia	26	1.1k 0.6×	792 0.7×	908 0.8×	401 0.6×	242 0.4×	76	2.2k
Vladimir S. Trubetskoy United States	22	2.5k 1.3×	1.1k 0.9×	1.9k 1.8×	737 1.0×	352 0.6×	37	4.6k

Countries citing papers authored by Petr Chytil

Since Specialization

Citations

This map shows the geographic impact of Petr Chytil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Chytil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Chytil more than expected).

Fields of papers citing papers by Petr Chytil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Chytil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Chytil. The network helps show where Petr Chytil may publish in the future.

Co-authorship network of co-authors of Petr Chytil

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Chytil. A scholar is included among the top collaborators of Petr Chytil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Chytil. Petr Chytil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klepac, Damir, Srećko Valić, Sami Kereı̈che, et al.. (2025). HPMA-based nitroxide radical containing nanoparticles with controlled radical release: Detailed physico-chemical characterization. European Polymer Journal. 225. 113727–113727.

Sanctis, Juan Bautista De, Lukáš Kubala, Petr Chytil, et al.. (2024). Polymer nanotherapeutics with the controlled release of acetylsalicylic acid and its derivatives inhibiting cyclooxygenase isoforms and reducing the production of pro-inflammatory mediators. International Journal of Pharmaceutics. 665. 124742–124742. 2 indexed citations

Tuřánek, Jaroslav, Petr Kosztyu, Pavlína Turánek Knötigová, et al.. (2024). Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: preparation, characterisation, and biological evaluation. International Journal of Pharmaceutics. 661. 124465–124465. 3 indexed citations

Šlouf, Miroslav, Libor Kobera, Ognen Pop‐Georgievski, et al.. (2023). Soft Hydrogels with Double Porosity Modified with RGDS for Tissue Engineering. Macromolecular Bioscience. 24(3). e2300266–e2300266. 8 indexed citations

Randárová, Eva, Hideaki Nakamura, Martin Studenovský, et al.. (2020). Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization. Acta Biomaterialia. 106. 256–266. 22 indexed citations

Etrych, Tomáš, Eva Pokorná, Jan Pankrác, et al.. (2018). Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging. Journal of Controlled Release. 289. 44–55. 31 indexed citations

Bojarová, Pavla, Dominic Laaf, Ladislav Bumba, et al.. (2018). Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3. Journal of Nanobiotechnology. 16(1). 73–73. 38 indexed citations

Islam, Waliul, Jun Fang, Tomáš Etrych, et al.. (2017). HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study. International Journal of Pharmaceutics. 536(1). 108–115. 14 indexed citations

Randárová, Eva, Petr Chytil, Tomáš Etrych, & Olga Janoušková. (2017). Ability of polymer-bound P-glycoprotein inhibitor ritonavir to overcome multidrug resistance in various resistant neuroblastoma cell lines. Anti-Cancer Drugs. 28(10). 1126–1130. 6 indexed citations

10.

Lucas, Henrike, et al.. (2016). Improved Tumor-Specific Drug Accumulation by Polymer Therapeutics with pH-Sensitive Drug Release Overcomes Chemotherapy Resistance. Molecular Cancer Therapeutics. 15(5). 998–1007. 30 indexed citations

11.

Etrych, Tomáš, Henrike Lucas, Olga Janoušková, et al.. (2016). Fluorescence optical imaging in anticancer drug delivery. Journal of Controlled Release. 226. 168–181. 109 indexed citations

12.

Šírová, Milada, J. Strohalm, Petr Chytil, et al.. (2016). The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel. Journal of Controlled Release. 246. 1–11. 24 indexed citations

13.

Yanazume, Shintaro, Hideaki Nakamura, Tomáš Etrych, et al.. (2015). HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases. Targeted Oncology. 11(1). 101–106. 77 indexed citations

14.

Chytil, Petr, Stefan Hoffmann, Libor Kostka, et al.. (2013). Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release II: Impact of release rate on biodistribution. Journal of Controlled Release. 172(2). 504–512. 45 indexed citations

15.

Nakamura, Hideaki, Tomáš Etrych, Petr Chytil, et al.. (2013). Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage. Journal of Controlled Release. 174. 81–87. 88 indexed citations

16.

Etrych, Tomáš, J. Strohalm, Petr Chytil, et al.. (2011). Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting. European Journal of Pharmaceutical Sciences. 42(5). 527–539. 92 indexed citations

17.

Kovář, Lubomír, Tomáš Etrych, Vladimír Šubr, et al.. (2010). Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells. Tumor Biology. 31(4). 233–242. 19 indexed citations

18.

Chytil, Petr, Tomáš Etrych, Jaroslav Křı́ž, Vladimír Šubr, & Karel Ulbrich. (2010). N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation. European Journal of Pharmaceutical Sciences. 41(3-4). 473–482. 122 indexed citations

19.

Chytil, Petr, Tomáš Etrych, Čestmı́r Koňák, et al.. (2006). Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification. Journal of Controlled Release. 115(1). 26–36. 78 indexed citations

20.

Ulbrich, Karel, et al.. (2004). Polymeric anticancer drugs with pH-controlled activation. International Journal of Pharmaceutics. 277(1-2). 63–72. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact